Analysis of LDLR mutations in familial hypercholesterolemia patients in Greece by use of the NanoChip® Microelectronic Array Technology

Clinica Chimica Acta

Volumn 374, Issue 1-2, 2006, Pages 93-99

  Laios, Eleftheria ^a   Drogari, Euridiki ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Detection; Greece; Hypercholesterolemia; LDLR; Mutation; NanoChip

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR; OLIGONUCLEOTIDE; STREPTAVIDIN;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA MICROARRAY; FAMILIAL HYPERCHOLESTEROLEMIA; GENE MUTATION; GENOTYPE; GREECE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL TECHNOLOGY; MICROARRAY ANALYSIS; MICROELECTRONIC ARRAY TECHNOLOGY; MOLECULAR BIOLOGY; MULTIPLEX POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

GENETIC SCREENING; GENETIC TESTING; GREECE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MICROARRAY ANALYSIS; MUTATION; NANOTECHNOLOGY; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, LDL; TIME FACTORS;

MONOPLEX;

EID: 33750216128     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.05.036     Document Type: Article

References (45)

1. Goldstein J.L., Hobbs H.H., and Brown M.S. Familial hypercholesterolemia. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The metabolic and molecular bases of inherited disease. 8th ed. vol. II (1995), McGraw Hill, New York 1981-2030
2. Villeger L., Abifadel M., Allard D., et al. The UMD-LDLR database: additions to the software and 490 new entries to the database. Hum Mutat 20 2 (2002) 81-87
3. Mavroidis N., Traeger-Synodinos J., Kanavakis E., et al. A high incidence of mutations in exon 6 of the low-density lipoprotein receptor gene in Greek familial hypercholesterolemia patients, including a novel mutation. Hum Mutat 9 3 (1997) 274-276
4. Traeger-Synodinos J., Mavroidis N., Kanavakis E., et al. Analysis of low density lipoprotein receptor gene mutations and microsatellite haplotypes in Greek FH heterozygous children: six independent ancestors account for 60% of probands. Hum Genet 102 3 (1998) 343-347
5. Miltiadous G., Elisaf M., Xenophontos S., Manoli P., and Cariolou M.A. Segregation of a novel LDLR gene mutation (I430T) with familial hypercholesterolaemia in a Greek pedigree. Hum Mutat 16 3 (2000) 277
6. Xenophontos S.L., Pierides A., Demetriou K., et al. Geographical clustering of low density lipoprotein receptor gene mutations (C292X; Q363X; D365E & C660X) in Cyprus. Hum Mutat 15 4 (2000) 380
7. Miltiadous G., Elisaf M., Bairaktari H., Xenophontos S.L., Manoli P., and Cariolou M.A. Characterization and geographic distribution of the low density lipoprotein receptor (LDLR) gene mutations in northwestern Greece. Hum Mutat 17 5 (2001) 432-433
8. Dedoussis G.V., Pitsavos C., Kelberman D., et al. FH-Pyrgos: a novel mutation in the promoter (- 45delT) of the low-density lipoprotein receptor gene associated with familial hypercholesterolemia. Clin Genet 64 5 (2003) 414-419
9. Dedoussis G.V., Genschel J., Bochow B., et al. Molecular characterization of familial hypercholesterolemia in German and Greek patients. Hum Mutat 23 3 (2004) 285-286
10. Dedoussis G.V., Skoumas J., Pitsavos C., et al. FH clinical phenotype in Greek patients with LDL-R defective vs. negative mutations. Eur J Clin Invest 34 6 (2004) 402-409
11. Leonard J.V., Whitelaw A.G., Wolff O.H., Lloyd J.K., and Slack J. Diagnosing familial hypercholesterolaemia in childhood by measuring serum cholesterol. Br Med J 1 6076 (1977) 1566-1568
12. Kwiterovich Jr. P.O., Fredrickson D.S., and Levy R.I. Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood. J Clin Invest 53 5 (1974) 1237-1249
13. Kastelein J.J. Screening for familial hypercholesterolaemia. Effective, safe treatments and DNA testing make screening attractive [Editorial]. BMJ 321 7275 (2000) 1483-1484
14. Humphries S.E., Gudnason V., Whittall R., and Day I.N. Single-strand conformation polymorphism analysis with high throughput modifications, and its use in mutation detection in familial hypercholesterolemia. International Federation of Clinical Chemistry Scientific Division: Committee on Molecular Biology Techniques. Clin Chem 43 3 (1997) 427-435
15. Whittall R., Gudnason V., Weavind G.P., Day L.B., Humphries S.E., and Day I.N. Utilities for high throughput use of the single strand conformational polymorphism method: screening of 791 patients with familial hypercholesterolaemia for mutations in exon 3 of the low density lipoprotein receptor gene. J Med Genet 32 7 (1995) 509-515
16. Reshef A., Nissen H., Triger L., et al. Molecular genetics of familial hypercholesterolemia in Israel. Hum Genet 98 5 (1996) 581-586
17. Day I.N., Whittall R.A., O'Dell S.D., et al. Spectrum of LDL receptor gene mutations in heterozygous familial hypercholesterolemia. Hum Mutat 10 2 (1997) 116-127
18. Nissen H., Guldberg P., Hansen A.B., Petersen N.E., and Horder M. Clinically applicable mutation screening in familial hypercholesterolemia. Hum Mutat 8 2 (1996) 168-177
19. Ekstrom U., Abrahamson M., Sveger T., Lombardi P., and Nilsson-Ehle P. An efficient screening procedure detecting six novel mutations in the LDL receptor gene in Swedish children with hypercholesterolemia. Hum Genet 96 2 (1995) 147-150
20. Bodamer O.A., Bercovich D., Schlabach M., Ballantyne C., Zoch D., and Beaudet A.L. Use of denaturing HPLC to provide efficient detection of mutations causing familial hypercholesterolemia. Clin Chem 48 11 (2002) 1913-1918
21. Naoumova R.P., Neuwirth C., Pottinger B., Whittal R., Humphries S.E., and Soutar A.K. Genetic diagnosis of familial hypercholesterolaemia: a mutation and a rare non-pathogenic amino acid variant in the same family. Atherosclerosis 174 1 (2004) 67-71
22. Liguori R., Argiriou A., and Simone V.D. A rapid method for detecting mutations of the human LDL receptor gene by complete cDNA sequencing. Mol Cell Probes 17 1 (2003) 15-20
23. Sozen M., Whittall R., and Humphries S.E. Mutation detection in patients with familial hypercholesterolaemia using heteroduplex and single strand conformation polymorphism analysis by capillary electrophoresis. Atheroscler Suppl 5 5 (2004) 7-11
24. Alharbi K.K., Aldahmesh M.A., Spanakis E., et al. Mutation scanning by meltMADGE: validations using BRCA1 and LDLR, and demonstration of the potential to identify severe, moderate, silent, rare, and paucimorphic mutations in the general population. Genome Res 15 7 (2005) 967-977
25. Heath K.E., Humphries S.E., Middleton-Price H., and Boxer M. A molecular genetic service for diagnosing individuals with familial hypercholesterolaemia (FH) in the United Kingdom. Eur J Hum Genet 9 4 (2001) 244-252
26. Fouchier S.W., Defesche J.C., Umans-Eckenhausen M.W., and Kastelein J.P. The molecular basis of familial hypercholesterolemia in The Netherlands. Hum Genet 109 6 (2001) 602-615
27. Umans-Eckenhausen M.A., Defesche J.C., Sijbrands E.J., Scheerder R.L., and Kastelein J.J. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Lancet 357 9251 (2001) 165-168
28. Umans-Eckenhausen M.A., Sijbrands E.J., Kastelein J.J., and Defesche J.C. Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population. Circulation 106 24 (2002) 3031-3036
29. Fouchier S.W., Kastelein J.P., and Defesche J.C. Update of the molecular basis of familial hypercholesterolemia in the Netherlands. Hum Mutat 26 6 (2005) 550-556
30. Tejedor D., Castillo S., Mozas P., et al. Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia. Clin Chem 51 7 (2005) 1137-1144
31. Leitersdorf E., Tobin E.J., Davignon J., and Hobbs H.H. Common low-density lipoprotein receptor mutations in the French Canadian population. J Clin Invest 85 4 (1990) 1014-1023
32. Kotze M.J., Langenhoven E., Warnich L., du Plessis L., and Retief A.E. The molecular basis and diagnosis of familial hypercholesterolaemia in South African Afrikaners. Ann Hum Genet 55 Pt 2 (1991) 115-121
33. Edman C.F., Raymond D.E., Wu D.J., et al. Electric field directed nucleic acid hybridization on microchips. Nucleic Acids Res 25 24 (1997) 4907-4914
34. Sosnowski R.G., Tu E., Butler W.F., O'Connell J.P., and Heller MJ. Rapid determination of single base mismatch mutations in DNA hybrids by direct electric field control. Proc Natl Acad Sci USA 94 4 (1997) 1119-1123
35. Heller M.J., Forster A.H., and Tu E. Active microeletronic chip devices which utilize controlled electrophoretic fields for multiplex DNA hybridization and other genomic applications. Electrophoresis 21 1 (2000) 157-164
36. Gurtner C., Tu E., Jamshidi N., et al. Microelectronic array devices and techniques for electric field enhanced DNA hybridization in low-conductance buffers. Electrophoresis 23 10 (2002) 1543-1550
37. Jensen H.K., Jensen L.G., Meinertz H., et al. Spectrum of LDL receptor gene mutations in Denmark: implications for molecular diagnostic strategy in heterozygous familial hypercholesterolemia. Atherosclerosis 146 (1999) 337-344
38. Santacroce R., Ratti A., Caroli F., et al. Analysis of clinically relevant single-nucleotide polymorphisms by use of microelectronic array technology. Clin Chem 48 12 (2002) 2124-2130
39. Erali M., Schmidt B., Lyon E., and Wittwer C. Evaluation of electronic microarrays for genotyping factor V, factor II, and MTHFR. Clin Chem 49 5 (2003) 732-739
40. Foglieni B., Cremonesi L., Travi M., et al. Beta-thalassemia microelectronic chip: a fast and accurate method for mutation detection. Clin Chem 50 1 (2004) 73-79
41. Moutereau S., Narwa R., Matheron C., Vongmany N., Simon E., and Goossens M. An improved electronic microarray-based diagnostic assay for identification of MEFV mutations. Hum Mutat 23 6 (2004) 621-628
42. Schrijver I., Lay M.J., and Zehnder J.L. Diagnostic single nucleotide polymorphism analysis of factor V Leiden and prothrombin 20210G > A. A comparison of the Nanogen Electronic Microarray with restriction enzyme digestion and the Roche LightCycler. Am J Clin Pathol 119 4 (2003) 490-496
43. Thistlethwaite W.A., Moses L.M., Hoffbuhr K.C., Devaney J.M., and Hoffman E.P. Rapid genotyping of common MeCP2 mutations with an electronic DNA microchip using serial differential hybridization. J Mol Diagn 5 2 (2003) 121-126
44. Evans J.G., and Lee-Tataseo C. Determination of the factor V Leiden single-nucleotide polymorphism in a commercial clinical laboratory by use of NanoChip microelectronic array technology. Clin Chem 48 9 (2002) 1406-1411
45. Sethi A.A., Tybjaerg-Hansen A., Andersen R.V., and Nordestgaard B.G. Nanogen microelectronic chip for large-scale genotyping. Clin Chem 50 2 (2004) 443-446